pharma · Gastric Cancer
Eastern Hepatobiliary Surgery
Eastern Hepatobiliary Surgery Hospital
Eastern Hepatobiliary Surgery is a pharma organization headquartered in CN. Primary therapeutic focus areas include Gastric Cancer. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to
CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Programs
- 1
- Drugs
- 4
- Patents
- 0
ENCITJ-GC01
Phase 3 · small molecule · Gastric Cancer
ENCITJ-GC01 for Gastric Cancer is a Phase 3 program (small_molecule) at Eastern Hepatobiliary Surgery Hospital with 1 ClinicalTrials.gov record(s).
Internal code ENCITJ-GC01
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Eastern Hepatobiliary Surgery Hospital
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Gastric Cancer
- Status
- terminated
- Trials
- 1